Financial News · Live Terminal

Page 214 of 226

Incyte Insider Sold Shares Worth $1,801,366, According to a Recent SEC Filing

Pablo J Cagnoni, President, Global Head of R&D, on April 17, 2026, sold 18,667 shares in Incyte (INCY) for $1,801,366. Following the Form 4 filing with the SEC, Cagnoni has control over a total of 262,692 common shares of the company, with 262,692 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/879169/000120570326000012/xslF345X05/wk-form4_1776802145.xml

$INCY

Insider Trading154d ago

Goldman Sachs Group Insider Sold Shares Worth $1,024,895, According to a Recent SEC Filing

Alex S Golten, Chief Risk Officer, on April 17, 2026, sold 1,115 shares in Goldman Sachs Group (GS) for $1,024,895. Following the Form 4 filing with the SEC, Golten has control over a total of 3,694 common shares of the company, with 3,694 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/886982/000205084926000012/xslF345X05/wk-form4_1776801830.xml

$GS

Insider Trading154d ago

Credit Acceptance Insider Sold Shares Worth $1,576,894, According to a Recent SEC Filing

Jay D Martin, Chief Financial Officer, on April 17, 2026, sold 3,000 shares in Credit Acceptance (CACC) for $1,576,894. Following the Form 4 filing with the SEC, Martin has control over a total of 25,963 common shares of the company, with 25,963 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/885550/000088555026000060/xslF345X05/wk-form4_1776801859.xml

$CACC

Insider Trading154d ago

Badger Meter Insider Bought Shares Worth $258,573, According to a Recent SEC Filing

Kenneth Bockhorst, Director, Chairman, President & CEO, on April 21, 2026, executed a purchase for 2,200 shares in Badger Meter (BMI) for $258,573. Following the Form 4 filing with the SEC, Bockhorst has control over a total of 51,676 common shares of the company, with 51,676 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/9092/000119312526166603/xslF345X05/ownership.xmlPrice: $119.35, Change: $+5.94, Percent Change: +5.23%

$BMI

Insider Trading154d ago

Davey Tree Expert Insider Sold Shares Worth $740,122, According to a Recent SEC Filing

Joseph R Paul, Director, Executive Vice President & CFO, on April 17, 2026, sold 26,816 shares in Davey Tree Expert (NONE) for $740,122. Following the Form 4 filing with the SEC, Paul has control over a total of 363,585 common shares of the company, with 339,413 shares held directly and 24,172 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/277638/000162828026026162/xslF345X05/wk-form4_1776787307.xml

$NONE

Insider Trading154d ago

Pagseguro Digital Insider Sold Shares Worth $2,252,000, According to a Recent SEC Filing

Alexandre Magnani, Director, on April 17, 2026, sold 200,000 shares in Pagseguro Digital (PAGS) for $2,252,000. Following the Form 4 filing with the SEC, Magnani has control over a total of 607,390 Class A common shares of the company, with 607,390 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1712807/000129281426002435/xslF345X05/ownership.xmlPrice: $11.31, Change: $-0.01, Percent Change: -0.09%

$PAGS

Insider Trading154d ago

Darden Restaurants Insider Sold Shares Worth $731,837, According to a Recent SEC Filing

Douglas J. Milanes, Senior Vice President, Chief Supply Chain Officer, on April 17, 2026, sold 3,620 shares in Darden Restaurants (DRI) for $731,837. Following the Form 4 filing with the SEC, Milanes has control over a total of 274 common shares of the company, with 274 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/940944/000122520826004575/xslF345X05/doc4.xmlPrice: $197.49, Change: $-4.36, Percent Change: -2.16%

$DRI

Insider Trading154d ago

Marvell Technology Insider Sold Shares Worth $1,355,000, According to a Recent SEC Filing

Mark Casper, Executive Vice President & Chief Legal Officer, on April 17, 2026, sold 10,000 shares in Marvell Technology (MRVL) for $1,355,000. Following the Form 4 filing with the SEC, Casper has control over a total of 46,141 common shares of the company, with 35,878 shares held directly and 10,263 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1835632/000162828026026152/xslF345X05/wk-form4_1776784235.xmlPrice: $151.25, Change: $+3.41, Percent Change: +2.30%

$MRVL

Insider Trading154d ago

United Therapeutics Insider Sold Shares Worth $5,778,607, According to a Recent SEC Filing

James Edgemond, CFO and Treasurer, on April 20, 2026, sold 10,000 shares in United Therapeutics (UTHR) for $5,778,607. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000163617826000011/xslF345X05/primarydocument.xmlPrice: $566.26, Change: $-7.19, Percent Change: -1.25%

$UTHR

Insider Trading154d ago

United Therapeutics Insider Sold Shares Worth $5,489,424, According to a Recent SEC Filing

Martine A Rothblatt, Director, Chairperson & CEO, on April 20, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,489,424. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,797 common shares of the company, with 40,513 shares held directly and 639,284 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000036/xslF345X05/primarydocument.xmlPrice: $565.14, Change: $-8.30, Percent Change: -1.45%

$UTHR

Insider Trading155d ago

Kailera Therapeutics Insider Bought Shares Worth $134,375,008, According to a Recent SEC Filing

Andrew T. Kaplan, 10% Owner, Director, on April 16, 2026, executed a purchase for 8,398,438 shares in Kailera Therapeutics (KLRA) for $134,375,008. Following the Form 4 filing with the SEC, Kaplan has control over a total of 26,255,581 common shares of the company, with 26,255,581 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2096997/000119312526164388/xslF345X05/ownership.xml

$KLRA

Insider Trading155d ago

Kailera Therapeutics Insider Bought Shares Worth $25,000,000, According to a Recent SEC Filing

Adam Koppel, 10% Owner, Director, on April 16, 2026, executed a purchase for 1,562,500 shares in Kailera Therapeutics (KLRA) for $25,000,000. Following the Form 4 filing with the SEC, Koppel has control over a total of 22,583,268 common shares of the company, with 22,583,268 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2096997/000119312526164407/xslF345X05/ownership.xml

$KLRA

Insider Trading155d ago

Scholar Rock Holding Insider Sold Shares Worth $1,517,723, According to a Recent SEC Filing

David Hallal, Director, Chief Executive Officer, on April 16, 2026, sold 30,615 shares in Scholar Rock Holding (SRRK) for $1,517,723. Following the Form 4 filing with the SEC, Hallal has control over a total of 1,844,034 common shares of the company, with 1,639,034 shares held directly and 205,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1727196/000110465926045581/xslF345X05/tm2612274-1_4seq1.xml

$SRRK

Insider Trading155d ago

Robinhood Markets Insider Sold Shares Worth $4,946,061, According to a Recent SEC Filing

Baiju Bhatt, Director, on April 16, 2026, sold 57,261 shares in Robinhood Markets (HOOD) for $4,946,061. Following the Form 4 filing with the SEC, Bhatt has control over a total of 2,778 Class A common shares of the company, with 2,778 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1783879/000187091426000009/xslF345X05/wk-form4_1776722859.xml

$HOOD

Insider Trading155d ago

Roivant Sciences Insider Sold Shares Worth $8,449,810, According to a Recent SEC Filing

Matthew Gline, Director, Chief Executive Officer, on April 16, 2026, sold 289,774 shares in Roivant Sciences (ROIV) for $8,449,810. Following the Form 4 filing with the SEC, Gline has control over a total of 16,736,116 common shares of the company, with 16,736,116 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1635088/000163508826000038/xslF345X05/wk-form4_1776724041.xml

$ROIV

Insider Trading155d ago

Reddit Insider Sold Shares Worth $6,324,169, According to a Recent SEC Filing

Jennifer L. Wong, Chief Operating Officer, on April 16, 2026, sold 39,167 shares in Reddit (RDDT) for $6,324,169. Following the Form 4 filing with the SEC, Wong has control over a total of 1,124,451 Class A common shares of the company, with 1,088,451 shares held directly and 36,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1713445/000166365126000007/xslF345X05/wk-form4_1776728047.xml

$RDDT

Insider Trading155d ago

Jabil Insider Sold Shares Worth $1,627,550, According to a Recent SEC Filing

Steven D Borges, Executive Vice President, Global Business Units, on April 17, 2026, sold 5,126 shares in Jabil (JBL) for $1,627,550. Following the Form 4 filing with the SEC, Borges has control over a total of 71,398 common shares of the company, with 71,398 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/898293/000122520826004572/xslF345X05/doc4.xml

$JBL

Insider Trading155d ago

Warby Parker Insider Sold Shares Worth $2,467,130, According to a Recent SEC Filing

Neil Harris Blumenthal, Director, Co-Chief Executive Officer, on April 16, 2026, sold 100,000 shares in Warby Parker (WRBY) for $2,467,130. Following the Form 4 filing with the SEC, Blumenthal has control over a total of 450,165 Class A common shares of the company, with 50,165 shares held directly and 400,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1504776/000110465926045607/xslF345X05/tm2612293-1_4seq1.xml

$WRBY

Insider Trading155d ago

Arxis Insider Bought Shares Worth $1,500,800, According to a Recent SEC Filing

Kevin Scott Perhamus, Director, President and Chief Executive Officer, on April 16, 2026, executed a purchase for 53,600 shares in Arxis (ARXS) for $1,500,800. Following the Form 4 filing with the SEC, Perhamus has control over a total of 3,573,133 Class A common shares of the company, with 3,573,133 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2093536/000119312526164663/xslF345X05/ownership.xml

$ARXS

Insider Trading155d ago

Aevex Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing

Brian Raduenz, Director, on April 16, 2026, executed a purchase for 50,000 shares in Aevex (AVEX) for $1,000,000. Following the Form 4 filing with the SEC, Raduenz has control over a total of 1,008,876 Class A common shares of the company, with 50,000 shares held directly and 958,876 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2096300/000119312526164668/xslF345X05/ownership.xml

$AVEX

Showing 4261-4280 of 4504